TOIIW
The Oncology Institute IncKey Statistics
About The Oncology Institute Inc
The Oncology Institute Inc. (TOIIW) is a prominent provider of specialized cancer care, dedicated to delivering high-quality and accessible treatment through an extensive network of outpatient facilities. The company emphasizes innovative therapies and a patient-centered approach, aiming to enhance clinical outcomes and improve the overall patient experience amid the increasing demand for specialized oncology services. With a robust strategy for growth and market penetration, The Oncology Institute represents a compelling opportunity for institutional investors looking to invest in the evolving cancer care landscape.
Fundamentals
| Revenue (TTM) | $545.76M |
| Gross Profit (TTM) | $82.50M |
| EBITDA | $-25.91M |
| Operating Margin | -4.42% |
| Return on Equity | -4132.00% |
| Return on Assets | -12.30% |
| Revenue/Share (TTM) | $5.54 |
| Book Value | $-0.16 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | 0 |
| Float | $87.26M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TOIIW and any ticker you trade — then tracks every position and per-strategy win rate.